206 / 490
204
INTERDISCIPLINARY RADIOBIOLOGY
CLINICAL BRACHYTHERAPY PHYSICS
RTT
YOUNG
POSTERS AND ELECTRONIC POSTERS
| PROGRAMME AND EXHIBITION GUIDE
POSTERS
> External beam radiotherapy with HDR brachytherapy boost in prostate
cancer: 5- and 8-year results
R. Soumarova (Czech Republic), T. Blažek, L. Homola
PO-0975
> HDR prostate brachytherapy: 3-D planned simultaneous integrated
boost to the peripheral zone
R. Hepp (Germany), L. Herberholz, A. Petry, T. Eggert, L. Piotrowski,
C. Morgenstern, G. Schabl, R. Galalae
PO-0976
> Ten year patient reported quality of life following I-125 prostate
brachytherapy monotherapy
A. Henry (UK), B. Sethugavalar, T. Witteveen, B. Al-Qaisieh,
P. Bownes, J. Smith, B. Carey, K. Franks, D. Mitchell, D. Bottomley
PO-0977
> Image-guided impact on the brachytherapy prostate treatment quality
V. Cerboneschi (Italy), V. Ravaglia, M. Paoluzzi, M. Mignogna,
M. Mignogna
PO-0978
> LTB control and toxicity for favorable and intmed Risk pts using real
time IO-PSI prostate BT alone
A. Raben (USA), A. Sarkar, A. Hanlon, H.C. Chen, F. Mourtada, A. Glick,
M. Lobis, S. Terranova, T. Desperito, D. Cozzolino
PO-0979
Poster
RADIOBIOLOGY TRACK: MOLECULAR TARGETED AGENTS
AND RADIOTHERAPY
> Inhibition of STAT3 enhances the radiosensitising effect of
Temozolomide in Glioblastoma model
I.A. Kim (Republic of Korea), T. Han, B. Cho, E. Choi, S. Song, S. Paek
PO-0980
> Activation of immune cells and enhanced efficacy of radiotherapy by
anti-TIP1 antibodies in cancer
D. Hallahan (USA), V. Kapoor, D. Thotala, H. Yan
PO-0981
> Therapeutic potential of the YB-1/Notch-3 interaction in prostate cancer
N. McDermott, A. Meunier, C. Haynes, A. Flores, A. O’Callaghan,
L. Marignol (Ireland)
PO-0982
> Nanoparticle mediated tumor vascular disruption: a novel strategy in
radiation therapy
S. Kunjachan (USA), A. Detappe, R. Kumar, S. Sridhar, G.M. Makrigiorgos,
R. Berbeco
PO-0983